nodes	percent_of_prediction	percent_of_DWPC	metapath
Albendazole—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0518	0.0706	CbGbCtD
Albendazole—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0487	0.0664	CbGbCtD
Albendazole—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0487	0.0664	CbGbCtD
Albendazole—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.044	0.06	CbGbCtD
Albendazole—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0425	0.0581	CbGbCtD
Albendazole—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0385	0.0525	CbGbCtD
Albendazole—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0369	0.0503	CbGbCtD
Albendazole—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0333	0.0455	CbGbCtD
Albendazole—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0332	0.0453	CbGbCtD
Albendazole—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.0322	0.044	CbGbCtD
Albendazole—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.0292	0.0398	CbGbCtD
Albendazole—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.0292	0.0398	CbGbCtD
Albendazole—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.028	0.0382	CbGbCtD
Albendazole—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0271	0.037	CbGbCtD
Albendazole—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0255	0.0348	CbGbCtD
Albendazole—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0255	0.0348	CbGbCtD
Albendazole—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0231	0.0315	CbGbCtD
Albendazole—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0231	0.0315	CbGbCtD
Albendazole—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.0216	0.0295	CbGbCtD
Albendazole—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0199	0.0272	CbGbCtD
Albendazole—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0193	0.0264	CbGbCtD
Albendazole—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0175	0.0238	CbGbCtD
Albendazole—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0175	0.0238	CbGbCtD
Albendazole—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0168	0.0229	CbGbCtD
Albendazole—TUBA1A—nerve—acquired immunodeficiency syndrome	0.00689	0.106	CbGeAlD
Albendazole—TUBA1A—Zalcitabine—Didanosine—acquired immunodeficiency syndrome	0.00291	0.423	CbGdCrCtD
Albendazole—TUBA1A—retina—acquired immunodeficiency syndrome	0.00285	0.044	CbGeAlD
Albendazole—TUBA1A—skin of body—acquired immunodeficiency syndrome	0.0025	0.0387	CbGeAlD
Albendazole—TUBA1A—Zidovudine—Stavudine—acquired immunodeficiency syndrome	0.00244	0.354	CbGdCrCtD
Albendazole—TUBA1A—lymphoid tissue—acquired immunodeficiency syndrome	0.00203	0.0313	CbGeAlD
Albendazole—TUBA1A—digestive system—acquired immunodeficiency syndrome	0.002	0.0309	CbGeAlD
Albendazole—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.00197	0.0304	CbGeAlD
Albendazole—TUBA1A—blood—acquired immunodeficiency syndrome	0.00191	0.0295	CbGeAlD
Albendazole—TUBB4B—retina—acquired immunodeficiency syndrome	0.0019	0.0294	CbGeAlD
Albendazole—TUBA1A—bone marrow—acquired immunodeficiency syndrome	0.00185	0.0285	CbGeAlD
Albendazole—TUBA1A—spinal cord—acquired immunodeficiency syndrome	0.00184	0.0284	CbGeAlD
Albendazole—TUBA1A—vagina—acquired immunodeficiency syndrome	0.00177	0.0273	CbGeAlD
Albendazole—TUBA1A—lung—acquired immunodeficiency syndrome	0.00167	0.0258	CbGeAlD
Albendazole—TUBB4B—skin of body—acquired immunodeficiency syndrome	0.00167	0.0258	CbGeAlD
Albendazole—TUBA1A—nervous system—acquired immunodeficiency syndrome	0.00155	0.0239	CbGeAlD
Albendazole—TUBA1A—Zalcitabine—Lamivudine—acquired immunodeficiency syndrome	0.00153	0.222	CbGdCrCtD
Albendazole—TUBA1A—central nervous system—acquired immunodeficiency syndrome	0.00149	0.023	CbGeAlD
Albendazole—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.00143	0.022	CbGeAlD
Albendazole—TUBB4B—lymphoid tissue—acquired immunodeficiency syndrome	0.00135	0.0209	CbGeAlD
Albendazole—TUBB4B—digestive system—acquired immunodeficiency syndrome	0.00133	0.0206	CbGeAlD
Albendazole—TUBB4B—blood—acquired immunodeficiency syndrome	0.00127	0.0196	CbGeAlD
Albendazole—TUBB4B—bone marrow—acquired immunodeficiency syndrome	0.00123	0.019	CbGeAlD
Albendazole—TUBB4B—spinal cord—acquired immunodeficiency syndrome	0.00123	0.0189	CbGeAlD
Albendazole—TUBA1A—brain—acquired immunodeficiency syndrome	0.00118	0.0183	CbGeAlD
Albendazole—TUBB4B—vagina—acquired immunodeficiency syndrome	0.00118	0.0182	CbGeAlD
Albendazole—TUBA1A—lymph node—acquired immunodeficiency syndrome	0.00114	0.0177	CbGeAlD
Albendazole—TUBB4B—lung—acquired immunodeficiency syndrome	0.00111	0.0172	CbGeAlD
Albendazole—TUBB4B—nervous system—acquired immunodeficiency syndrome	0.00103	0.0159	CbGeAlD
Albendazole—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.00101	0.0156	CbGeAlD
Albendazole—TUBB4B—central nervous system—acquired immunodeficiency syndrome	0.000994	0.0153	CbGeAlD
Albendazole—Immune system disorder—Nevirapine—acquired immunodeficiency syndrome	0.000978	0.005	CcSEcCtD
Albendazole—Erythema multiforme—Abacavir—acquired immunodeficiency syndrome	0.000973	0.00498	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Amprenavir—acquired immunodeficiency syndrome	0.000972	0.00497	CcSEcCtD
Albendazole—Hepatobiliary disease—Zidovudine—acquired immunodeficiency syndrome	0.000957	0.00489	CcSEcCtD
Albendazole—Pancytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000947	0.00484	CcSEcCtD
Albendazole—Immune system disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000947	0.00484	CcSEcCtD
Albendazole—Agranulocytosis—Zidovudine—acquired immunodeficiency syndrome	0.000944	0.00483	CcSEcCtD
Albendazole—Liver function test abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000942	0.00482	CcSEcCtD
Albendazole—Leukopenia—Didanosine—acquired immunodeficiency syndrome	0.000938	0.0048	CcSEcCtD
Albendazole—CYP1A1—skin of body—acquired immunodeficiency syndrome	0.000935	0.0144	CbGeAlD
Albendazole—Stevens-Johnson syndrome—Indinavir—acquired immunodeficiency syndrome	0.000933	0.00477	CcSEcCtD
Albendazole—Immune system disorder—Abacavir—acquired immunodeficiency syndrome	0.00093	0.00476	CcSEcCtD
Albendazole—Skin disorder—Amprenavir—acquired immunodeficiency syndrome	0.000911	0.00466	CcSEcCtD
Albendazole—Alopecia—Abacavir—acquired immunodeficiency syndrome	0.00091	0.00465	CcSEcCtD
Albendazole—Hepatitis—Zidovudine—acquired immunodeficiency syndrome	0.000908	0.00464	CcSEcCtD
Albendazole—Liver function test abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000907	0.00464	CcSEcCtD
Albendazole—Pancytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000906	0.00463	CcSEcCtD
Albendazole—Urinary tract disorder—Zidovudine—acquired immunodeficiency syndrome	0.000897	0.00459	CcSEcCtD
Albendazole—Neutropenia—Delavirdine—acquired immunodeficiency syndrome	0.000892	0.00456	CcSEcCtD
Albendazole—Urethral disorder—Zidovudine—acquired immunodeficiency syndrome	0.00089	0.00455	CcSEcCtD
Albendazole—Hepatobiliary disease—Indinavir—acquired immunodeficiency syndrome	0.00089	0.00455	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Efavirenz—acquired immunodeficiency syndrome	0.000881	0.00451	CcSEcCtD
Albendazole—Liver function test abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000865	0.00443	CcSEcCtD
Albendazole—Erythema multiforme—Zidovudine—acquired immunodeficiency syndrome	0.000859	0.00439	CcSEcCtD
Albendazole—Hepatitis—Indinavir—acquired immunodeficiency syndrome	0.000845	0.00432	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Delavirdine—acquired immunodeficiency syndrome	0.000843	0.00431	CcSEcCtD
Albendazole—Hepatobiliary disease—Efavirenz—acquired immunodeficiency syndrome	0.000841	0.0043	CcSEcCtD
Albendazole—Thrombocytopenia—Didanosine—acquired immunodeficiency syndrome	0.000837	0.00428	CcSEcCtD
Albendazole—Urinary tract disorder—Indinavir—acquired immunodeficiency syndrome	0.000834	0.00427	CcSEcCtD
Albendazole—Urethral disorder—Indinavir—acquired immunodeficiency syndrome	0.000828	0.00423	CcSEcCtD
Albendazole—Neutropenia—Ritonavir—acquired immunodeficiency syndrome	0.000825	0.00422	CcSEcCtD
Albendazole—Leukopenia—Nelfinavir—acquired immunodeficiency syndrome	0.000817	0.00418	CcSEcCtD
Albendazole—Leukopenia—Stavudine—acquired immunodeficiency syndrome	0.000814	0.00416	CcSEcCtD
Albendazole—Pancytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000806	0.00412	CcSEcCtD
Albendazole—Vertigo—Abacavir—acquired immunodeficiency syndrome	0.000805	0.00412	CcSEcCtD
Albendazole—Leukopenia—Abacavir—acquired immunodeficiency syndrome	0.000802	0.0041	CcSEcCtD
Albendazole—Erythema multiforme—Indinavir—acquired immunodeficiency syndrome	0.000799	0.00408	CcSEcCtD
Albendazole—Hepatitis—Efavirenz—acquired immunodeficiency syndrome	0.000798	0.00408	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Nevirapine—acquired immunodeficiency syndrome	0.000797	0.00407	CcSEcCtD
Albendazole—Neutropenia—Saquinavir—acquired immunodeficiency syndrome	0.000794	0.00406	CcSEcCtD
Albendazole—TUBB4B—brain—acquired immunodeficiency syndrome	0.000789	0.0122	CbGeAlD
Albendazole—Urinary tract disorder—Efavirenz—acquired immunodeficiency syndrome	0.000788	0.00403	CcSEcCtD
Albendazole—Urethral disorder—Efavirenz—acquired immunodeficiency syndrome	0.000782	0.004	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Nelfinavir—acquired immunodeficiency syndrome	0.000771	0.00395	CcSEcCtD
Albendazole—Pancytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000769	0.00393	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Stavudine—acquired immunodeficiency syndrome	0.000769	0.00393	CcSEcCtD
Albendazole—Gastrointestinal pain—Amprenavir—acquired immunodeficiency syndrome	0.000767	0.00392	CcSEcCtD
Albendazole—Hepatitis—Delavirdine—acquired immunodeficiency syndrome	0.000764	0.00391	CcSEcCtD
Albendazole—Immune system disorder—Indinavir—acquired immunodeficiency syndrome	0.000763	0.0039	CcSEcCtD
Albendazole—TUBB4B—lymph node—acquired immunodeficiency syndrome	0.000763	0.0118	CbGeAlD
Albendazole—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000758	0.0117	CbGeAlD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Abacavir—acquired immunodeficiency syndrome	0.000758	0.00387	CcSEcCtD
Albendazole—Neutropenia—Lamivudine—acquired immunodeficiency syndrome	0.000757	0.00387	CcSEcCtD
Albendazole—Erythema multiforme—Efavirenz—acquired immunodeficiency syndrome	0.000755	0.00386	CcSEcCtD
Albendazole—Thrombocytopenia—Nevirapine—acquired immunodeficiency syndrome	0.000753	0.00385	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Saquinavir—acquired immunodeficiency syndrome	0.000751	0.00384	CcSEcCtD
Albendazole—CYP1A1—digestive system—acquired immunodeficiency syndrome	0.000747	0.0115	CbGeAlD
Albendazole—Skin disorder—Nevirapine—acquired immunodeficiency syndrome	0.000747	0.00382	CcSEcCtD
Albendazole—Alopecia—Indinavir—acquired immunodeficiency syndrome	0.000746	0.00382	CcSEcCtD
Albendazole—Hepatobiliary disease—Ritonavir—acquired immunodeficiency syndrome	0.000744	0.0038	CcSEcCtD
Albendazole—Abdominal pain—Amprenavir—acquired immunodeficiency syndrome	0.000742	0.00379	CcSEcCtD
Albendazole—Thrombocytopenia—Nelfinavir—acquired immunodeficiency syndrome	0.000729	0.00373	CcSEcCtD
Albendazole—Thrombocytopenia—Stavudine—acquired immunodeficiency syndrome	0.000727	0.00372	CcSEcCtD
Albendazole—Skin disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000723	0.0037	CcSEcCtD
Albendazole—Erythema multiforme—Delavirdine—acquired immunodeficiency syndrome	0.000722	0.00369	CcSEcCtD
Albendazole—CYP1A2—blood—acquired immunodeficiency syndrome	0.000722	0.0111	CbGeAlD
Albendazole—Skin disorder—Stavudine—acquired immunodeficiency syndrome	0.000721	0.00369	CcSEcCtD
Albendazole—Immune system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000721	0.00369	CcSEcCtD
Albendazole—Thrombocytopenia—Abacavir—acquired immunodeficiency syndrome	0.000716	0.00366	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Lamivudine—acquired immunodeficiency syndrome	0.000716	0.00366	CcSEcCtD
Albendazole—Hepatobiliary disease—Saquinavir—acquired immunodeficiency syndrome	0.000716	0.00366	CcSEcCtD
Albendazole—CYP1A1—blood—acquired immunodeficiency syndrome	0.000712	0.011	CbGeAlD
Albendazole—Skin disorder—Abacavir—acquired immunodeficiency syndrome	0.00071	0.00363	CcSEcCtD
Albendazole—Vertigo—Zidovudine—acquired immunodeficiency syndrome	0.00071	0.00363	CcSEcCtD
Albendazole—Leukopenia—Zidovudine—acquired immunodeficiency syndrome	0.000708	0.00362	CcSEcCtD
Albendazole—Hepatitis—Ritonavir—acquired immunodeficiency syndrome	0.000706	0.00361	CcSEcCtD
Albendazole—Alopecia—Efavirenz—acquired immunodeficiency syndrome	0.000705	0.00361	CcSEcCtD
Albendazole—Gastrointestinal pain—Didanosine—acquired immunodeficiency syndrome	0.000699	0.00358	CcSEcCtD
Albendazole—Urinary tract disorder—Ritonavir—acquired immunodeficiency syndrome	0.000697	0.00357	CcSEcCtD
Albendazole—Urethral disorder—Ritonavir—acquired immunodeficiency syndrome	0.000692	0.00354	CcSEcCtD
Albendazole—Hepatobiliary disease—Lamivudine—acquired immunodeficiency syndrome	0.000683	0.00349	CcSEcCtD
Albendazole—Hepatitis—Saquinavir—acquired immunodeficiency syndrome	0.00068	0.00348	CcSEcCtD
Albendazole—Abdominal pain—Didanosine—acquired immunodeficiency syndrome	0.000676	0.00346	CcSEcCtD
Albendazole—Body temperature increased—Didanosine—acquired immunodeficiency syndrome	0.000676	0.00346	CcSEcCtD
Albendazole—Alopecia—Delavirdine—acquired immunodeficiency syndrome	0.000675	0.00345	CcSEcCtD
Albendazole—Agranulocytosis—Lamivudine—acquired immunodeficiency syndrome	0.000674	0.00345	CcSEcCtD
Albendazole—Urinary tract disorder—Saquinavir—acquired immunodeficiency syndrome	0.000671	0.00343	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Zidovudine—acquired immunodeficiency syndrome	0.000668	0.00342	CcSEcCtD
Albendazole—Erythema multiforme—Ritonavir—acquired immunodeficiency syndrome	0.000668	0.00341	CcSEcCtD
Albendazole—Urethral disorder—Saquinavir—acquired immunodeficiency syndrome	0.000666	0.00341	CcSEcCtD
Albendazole—Vertigo—Indinavir—acquired immunodeficiency syndrome	0.000661	0.00338	CcSEcCtD
Albendazole—CYP1A1—vagina—acquired immunodeficiency syndrome	0.00066	0.0102	CbGeAlD
Albendazole—Hepatitis—Lamivudine—acquired immunodeficiency syndrome	0.000648	0.00332	CcSEcCtD
Albendazole—Erythema multiforme—Saquinavir—acquired immunodeficiency syndrome	0.000643	0.00329	CcSEcCtD
Albendazole—Immune system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000638	0.00326	CcSEcCtD
Albendazole—CYP1A2—lung—acquired immunodeficiency syndrome	0.000633	0.00977	CbGeAlD
Albendazole—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.000632	0.00323	CcSEcCtD
Albendazole—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.00063	0.00322	CcSEcCtD
Albendazole—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.000629	0.00322	CcSEcCtD
Albendazole—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.000627	0.00321	CcSEcCtD
Albendazole—CYP1A1—lung—acquired immunodeficiency syndrome	0.000624	0.00964	CbGeAlD
Albendazole—Vertigo—Efavirenz—acquired immunodeficiency syndrome	0.000624	0.00319	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.000622	0.00318	CcSEcCtD
Albendazole—Immune system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000614	0.00314	CcSEcCtD
Albendazole—Erythema multiforme—Lamivudine—acquired immunodeficiency syndrome	0.000613	0.00314	CcSEcCtD
Albendazole—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.000611	0.00312	CcSEcCtD
Albendazole—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000609	0.00311	CcSEcCtD
Albendazole—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.000608	0.00311	CcSEcCtD
Albendazole—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.000608	0.00311	CcSEcCtD
Albendazole—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.000607	0.0031	CcSEcCtD
Albendazole—Alopecia—Saquinavir—acquired immunodeficiency syndrome	0.000601	0.00307	CcSEcCtD
Albendazole—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.000598	0.00306	CcSEcCtD
Albendazole—Vertigo—Delavirdine—acquired immunodeficiency syndrome	0.000597	0.00305	CcSEcCtD
Albendazole—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000596	0.00305	CcSEcCtD
Albendazole—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.000595	0.00304	CcSEcCtD
Albendazole—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000592	0.00303	CcSEcCtD
Albendazole—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000591	0.00302	CcSEcCtD
Albendazole—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000591	0.00302	CcSEcCtD
Albendazole—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.00059	0.00302	CcSEcCtD
Albendazole—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.000589	0.00301	CcSEcCtD
Albendazole—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000589	0.00301	CcSEcCtD
Albendazole—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000588	0.00301	CcSEcCtD
Albendazole—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.000588	0.003	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.000587	0.003	CcSEcCtD
Albendazole—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000587	0.003	CcSEcCtD
Albendazole—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.000587	0.003	CcSEcCtD
Albendazole—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000586	0.003	CcSEcCtD
Albendazole—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.000583	0.00298	CcSEcCtD
Albendazole—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000581	0.00297	CcSEcCtD
Albendazole—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000578	0.00296	CcSEcCtD
Albendazole—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000578	0.00296	CcSEcCtD
Albendazole—CYP1A1—nervous system—acquired immunodeficiency syndrome	0.000578	0.00893	CbGeAlD
Albendazole—Alopecia—Lamivudine—acquired immunodeficiency syndrome	0.000573	0.00293	CcSEcCtD
Albendazole—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000566	0.0029	CcSEcCtD
Albendazole—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000557	0.00285	CcSEcCtD
Albendazole—CYP1A1—central nervous system—acquired immunodeficiency syndrome	0.000557	0.00859	CbGeAlD
Albendazole—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000555	0.00284	CcSEcCtD
Albendazole—ABCB1—retina—acquired immunodeficiency syndrome	0.000553	0.00854	CbGeAlD
Albendazole—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000552	0.00282	CcSEcCtD
Albendazole—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000551	0.00282	CcSEcCtD
Albendazole—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.00055	0.00281	CcSEcCtD
Albendazole—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000549	0.00281	CcSEcCtD
Albendazole—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000549	0.00847	CbGeAlD
Albendazole—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000547	0.0028	CcSEcCtD
Albendazole—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000544	0.00278	CcSEcCtD
Albendazole—Rash—Didanosine—acquired immunodeficiency syndrome	0.000539	0.00276	CcSEcCtD
Albendazole—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000539	0.00276	CcSEcCtD
Albendazole—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000539	0.00275	CcSEcCtD
Albendazole—Headache—Didanosine—acquired immunodeficiency syndrome	0.000536	0.00274	CcSEcCtD
Albendazole—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000532	0.00272	CcSEcCtD
Albendazole—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000531	0.00272	CcSEcCtD
Albendazole—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.00053	0.00271	CcSEcCtD
Albendazole—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000528	0.0027	CcSEcCtD
Albendazole—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000527	0.00269	CcSEcCtD
Albendazole—CYP3A4—blood—acquired immunodeficiency syndrome	0.000523	0.00807	CbGeAlD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.00052	0.00266	CcSEcCtD
Albendazole—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000513	0.00262	CcSEcCtD
Albendazole—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.00051	0.00261	CcSEcCtD
Albendazole—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.00051	0.00261	CcSEcCtD
Albendazole—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000508	0.0026	CcSEcCtD
Albendazole—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000507	0.00259	CcSEcCtD
Albendazole—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000505	0.00258	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.0005	0.00256	CcSEcCtD
Albendazole—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000492	0.00252	CcSEcCtD
Albendazole—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000491	0.00251	CcSEcCtD
Albendazole—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000491	0.00251	CcSEcCtD
Albendazole—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000491	0.00251	CcSEcCtD
Albendazole—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000489	0.0025	CcSEcCtD
Albendazole—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000487	0.00249	CcSEcCtD
Albendazole—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000485	0.00248	CcSEcCtD
Albendazole—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000484	0.00248	CcSEcCtD
Albendazole—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000484	0.00247	CcSEcCtD
Albendazole—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000482	0.00246	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000477	0.00244	CcSEcCtD
Albendazole—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000477	0.00244	CcSEcCtD
Albendazole—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000474	0.00243	CcSEcCtD
Albendazole—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000474	0.00243	CcSEcCtD
Albendazole—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000473	0.00242	CcSEcCtD
Albendazole—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000473	0.00242	CcSEcCtD
Albendazole—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000472	0.00241	CcSEcCtD
Albendazole—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00047	0.0024	CcSEcCtD
Albendazole—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000469	0.0024	CcSEcCtD
Albendazole—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000469	0.0024	CcSEcCtD
Albendazole—Rash—Stavudine—acquired immunodeficiency syndrome	0.000468	0.00239	CcSEcCtD
Albendazole—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000468	0.00239	CcSEcCtD
Albendazole—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000467	0.00239	CcSEcCtD
Albendazole—Headache—Stavudine—acquired immunodeficiency syndrome	0.000465	0.00238	CcSEcCtD
Albendazole—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000465	0.00238	CcSEcCtD
Albendazole—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000464	0.00237	CcSEcCtD
Albendazole—Rash—Abacavir—acquired immunodeficiency syndrome	0.000461	0.00236	CcSEcCtD
Albendazole—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000461	0.00236	CcSEcCtD
Albendazole—Headache—Abacavir—acquired immunodeficiency syndrome	0.000458	0.00234	CcSEcCtD
Albendazole—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000457	0.00234	CcSEcCtD
Albendazole—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000451	0.00231	CcSEcCtD
Albendazole—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.00045	0.0023	CcSEcCtD
Albendazole—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000448	0.00229	CcSEcCtD
Albendazole—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000448	0.00229	CcSEcCtD
Albendazole—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000447	0.00229	CcSEcCtD
Albendazole—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000444	0.00227	CcSEcCtD
Albendazole—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000442	0.00226	CcSEcCtD
Albendazole—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000442	0.00226	CcSEcCtD
Albendazole—CYP1A1—brain—acquired immunodeficiency syndrome	0.000442	0.00682	CbGeAlD
Albendazole—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000441	0.00226	CcSEcCtD
Albendazole—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000434	0.00222	CcSEcCtD
Albendazole—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000431	0.0022	CcSEcCtD
Albendazole—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000429	0.00219	CcSEcCtD
Albendazole—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000429	0.00219	CcSEcCtD
Albendazole—CYP1A1—lymph node—acquired immunodeficiency syndrome	0.000427	0.00659	CbGeAlD
Albendazole—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000427	0.00218	CcSEcCtD
Albendazole—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000424	0.00655	CbGeAlD
Albendazole—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000418	0.00214	CcSEcCtD
Albendazole—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00041	0.0021	CcSEcCtD
Albendazole—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.00041	0.0021	CcSEcCtD
Albendazole—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000408	0.00631	CbGeAlD
Albendazole—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000407	0.00208	CcSEcCtD
Albendazole—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000406	0.00208	CcSEcCtD
Albendazole—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000404	0.00207	CcSEcCtD
Albendazole—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.0004	0.00204	CcSEcCtD
Albendazole—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000399	0.00204	CcSEcCtD
Albendazole—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000397	0.00203	CcSEcCtD
Albendazole—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000397	0.00203	CcSEcCtD
Albendazole—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000397	0.00203	CcSEcCtD
Albendazole—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000395	0.00202	CcSEcCtD
Albendazole—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000393	0.00607	CbGeAlD
Albendazole—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000388	0.006	CbGeAlD
Albendazole—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000384	0.00196	CcSEcCtD
Albendazole—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000383	0.00196	CcSEcCtD
Albendazole—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000382	0.00195	CcSEcCtD
Albendazole—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000382	0.00195	CcSEcCtD
Albendazole—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000382	0.00195	CcSEcCtD
Albendazole—Rash—Indinavir—acquired immunodeficiency syndrome	0.000378	0.00194	CcSEcCtD
Albendazole—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000378	0.00193	CcSEcCtD
Albendazole—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000377	0.00193	CcSEcCtD
Albendazole—Headache—Indinavir—acquired immunodeficiency syndrome	0.000376	0.00192	CcSEcCtD
Albendazole—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000375	0.00192	CcSEcCtD
Albendazole—ABCB1—blood—acquired immunodeficiency syndrome	0.00037	0.00571	CbGeAlD
Albendazole—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.00037	0.00189	CcSEcCtD
Albendazole—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000366	0.00187	CcSEcCtD
Albendazole—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000364	0.00186	CcSEcCtD
Albendazole—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000364	0.00186	CcSEcCtD
Albendazole—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.00036	0.00184	CcSEcCtD
Albendazole—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000359	0.00183	CcSEcCtD
Albendazole—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000358	0.00553	CbGeAlD
Albendazole—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000357	0.00183	CcSEcCtD
Albendazole—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000357	0.00183	CcSEcCtD
Albendazole—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000356	0.00182	CcSEcCtD
Albendazole—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000356	0.0055	CbGeAlD
Albendazole—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000356	0.00182	CcSEcCtD
Albendazole—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000355	0.00182	CcSEcCtD
Albendazole—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000345	0.00176	CcSEcCtD
Albendazole—ABCB1—vagina—acquired immunodeficiency syndrome	0.000343	0.00529	CbGeAlD
Albendazole—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000342	0.00175	CcSEcCtD
Albendazole—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000342	0.00175	CcSEcCtD
Albendazole—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00034	0.00174	CcSEcCtD
Albendazole—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000339	0.00174	CcSEcCtD
Albendazole—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000337	0.00172	CcSEcCtD
Albendazole—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000332	0.0017	CcSEcCtD
Albendazole—ABCB1—lung—acquired immunodeficiency syndrome	0.000324	0.00501	CbGeAlD
Albendazole—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000322	0.00165	CcSEcCtD
Albendazole—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000319	0.00163	CcSEcCtD
Albendazole—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000319	0.00163	CcSEcCtD
Albendazole—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000316	0.00162	CcSEcCtD
Albendazole—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000316	0.00162	CcSEcCtD
Albendazole—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000314	0.00161	CcSEcCtD
Albendazole—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000307	0.00157	CcSEcCtD
Albendazole—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000305	0.00156	CcSEcCtD
Albendazole—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000304	0.00156	CcSEcCtD
Albendazole—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000304	0.00156	CcSEcCtD
Albendazole—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000302	0.00155	CcSEcCtD
Albendazole—ABCB1—nervous system—acquired immunodeficiency syndrome	0.0003	0.00464	CbGeAlD
Albendazole—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000298	0.00152	CcSEcCtD
Albendazole—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000293	0.0015	CcSEcCtD
Albendazole—Rash—Lamivudine—acquired immunodeficiency syndrome	0.00029	0.00149	CcSEcCtD
Albendazole—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.00029	0.00148	CcSEcCtD
Albendazole—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000289	0.00446	CbGeAlD
Albendazole—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000289	0.00148	CcSEcCtD
Albendazole—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000287	0.00147	CcSEcCtD
Albendazole—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000274	0.0014	CcSEcCtD
Albendazole—ABCB1—brain—acquired immunodeficiency syndrome	0.00023	0.00354	CbGeAlD
Albendazole—ABCB1—lymph node—acquired immunodeficiency syndrome	0.000222	0.00342	CbGeAlD
